June 21, 2024 07:00 AM EDT
Peer Review

Mon­cef Slaoui joins board at mR­NA biotech; Gami­da Cell re­tools with ex-Am­ryt CEO at the helm

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Mon­cef Slaoui has reemerged this week with an­oth­er board ap­point­ment, mak­ing his way to mR­NA drug de­vel­op­er Arc­turus Ther­a­peu­tics. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times